Showing results (101-110 of 161) with videos related to
Sort By:
Pageof 17
JFMS Open Reports|January 6, 2021
Primary hyperparathyroidism caused by bilateral parathyroid cystic carcinoma in a catJuulia K Virtanen, Sari H Mölsä, Karoliina A Hagner, et al.Current Eye Research|March 1, 1989
Tissue-type plasminogen activator in subretinal fluidI Immonen, R W Stephens, E M Salonen, et al.Journal of the American Veterinary Medical Association|March 16, 2006
Evaluation of adverse effects of long-term orally administered carprofen in dogsMarja R Raekallio, Anna K Hielm-Björkman, Johanna Kejonen, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|April 13, 2018
Orthogonal Clickable Iron Oxide Nanoparticle Platform for Targeting, Imaging, and On-Demand ReleaseNoelia Guldris, Juan Gallo, Lorena García-Hevia, et al.Current Eye Research|March 1, 1992
Tear plasmin activity with contact lens wearA Vannas, D F Sweeney, B A Holden, et al.Experimental Eye Research|February 1, 1990
Effects of the Schirmer test on the fibrinolytic system in the tear fluidG B van Setten, R Stephens, T Tervo, et al.The Journal of Cell Biology|April 1, 1987
Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cellsJ Pöllänen, O Saksela, E M Salonen, et al.Journal of Hazardous Materials|March 24, 2023
A carboxyl-functionalized covalent organic polymer for the efficient adsorption of saxitoxinTianxing Wang, Soraia P S Fernandes, Joana Araújo, et al.Journal of Medical Virology|February 24, 2000
A neutralizing recombinant human antibody Fab fragment against Puumala hantavirusC de Carvalho Nicacio, A Lundkvist, K B Sjölander, et al.British Journal of Anaesthesia|February 11, 2011
Pharmacokinetics of ropivacaine in patients with chronic renal failureP J Pere, A Ekstrand, M Salonen, et al.Pageof 17